STOCK TITAN

Dominari Holdings Inc. Form 4 Filings

DOMH NASDAQ

Every Form 4 that Dominari Holdings Inc. (DOMH) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow DOMH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DOMH filings page.

Rhea-AI Summary

Dominari Holdings Inc. (DOMH) reports that CEO and director Anthony Hayes purchased a total of 100,000 shares of Class A common stock in open market transactions. He bought 50,000 shares on September 10, 2026 at a weighted average price of $2.0211 per share and another 50,000 shares on September 11, 2026 at a weighted average price of $2.1627 per share. The prices are disclosed as weighted averages, and no Rule 10b5-1 trading plan is reported in connection with these purchases.

Rhea-AI Summary

Dominari Holdings Inc. (DOMH) disclosed that President and director Kyle Michael Wool purchased company common stock in the open market on two consecutive days. He bought 50,000 shares on September 10, 2026 at a weighted average price of $2.0211 per share and another 50,000 shares on September 11, 2026 at a weighted average price of $2.1627 per share, for a total of 100,000 shares acquired. The filing states these prices are weighted averages and notes no Rule 10b5-1 trading plan.

Rhea-AI Summary

Dominari Holdings CEO and director Anthony Hayes reported a bona fide charitable gift of 250,000 shares of common stock on July 27, 2026, transferring them to Hayes Charitable Foundation. The filing states he received no value for the gifted shares. After the transaction, Hayes directly owns 4,500,873 shares of Dominari common stock. The Rule 10b5-1 trading-plan checkbox for this transaction was left unchecked.

Rhea-AI Summary

Dominari Holdings Inc. reported that its Chief Financial Officer, Tim S. Ledwick, received a grant of stock options on July 1, 2026. The grant covers 20,000 stock options, each allowing the purchase of one share of common stock at an exercise price of $3.05 per share. According to the disclosure, these options were issued under the company’s 2022 Equity Incentive Plan, are not currently exercisable, and will become exercisable on July 1, 2027. The options are scheduled to expire on July 1, 2036, and this grant results in Ledwick holding 20,000 stock options directly following the transaction.

Rhea-AI Summary

Dominari Holdings Inc. director Gregory James Blattner received a grant of stock options covering 20,000 shares of common stock as equity compensation. The options have an exercise price of $3.05 per share, become exercisable on July 1, 2027, and expire on July 1, 2036.

Rhea-AI Summary

Dominari Holdings Inc. director Brian Keith Parsley received a grant of stock options as part of his compensation. He was awarded options covering 20,000 shares of common stock with an exercise price of $3.05 per share. The options were granted on July 1, 2026 under the company’s 2022 Equity Incentive Plan and will become exercisable on July 1, 2027. If not exercised earlier, these options will expire on July 1, 2036, giving the director a long-term incentive tied to the company’s share price.

Rhea-AI Summary

Dominari Holdings Inc. director Kyle Haug received a grant of stock options covering 20,000 shares of common stock. The options were granted on July 1, 2026 under the company’s 2022 Equity Incentive Plan with an exercise price of $3.05 per share.

The options become exercisable on July 1, 2027 and are scheduled to expire on July 1, 2036. Following this grant, Haug holds 20,000 stock options directly, reflecting a compensation-related award rather than an open‑market trade.

Rhea-AI Summary

Dominari Holdings Inc. COO Christopher Franklin received a grant of stock options covering 20,000 shares of common stock. The options were awarded on July 1, 2026 under the company’s 2022 Equity Incentive Plan with an exercise price of $3.05 per share.

The options become exercisable on July 1, 2027 and expire on July 1, 2036, giving the executive a long‑term incentive tied to Dominari’s share price performance. Following this grant, he holds 20,000 stock options directly.

Rhea-AI Summary

LEDWICK TIM S reported acquisition or exercise transactions in this Form 4 filing.

Dominari Holdings Inc. reported that its Chief Financial Officer, Tim S. Ledwick, received a grant of 316,346 shares of restricted common stock on January 9, 2026 under the 2022 Equity Incentive Plan. The award carries no purchase price and is compensation-related, not an open-market transaction.

The restricted stock will vest on the earlier of September 30, 2026 or an Acceleration Event, which includes a change in control, certain terminations without cause or for good reason, or the CFO’s death or total disability. Following this grant, he directly holds 347,817 shares of Dominari common stock.

Rhea-AI Summary

Hayes Anthony reported acquisition or exercise transactions in this Form 4 filing.

Dominari Holdings Inc. reported that CEO Anthony Hayes received a grant of 3,000,000 shares of common stock as equity compensation. The award was made under the 2022 Equity Incentive Plan at a stated price of $0.00 per share. The grant was originally conditioned on stockholder approval of an amendment to the plan obtained on March 4, 2026, and registration of the shares on Form S-8 completed on March 13, 2026. After this issuance, Hayes directly holds 4,750,873 common shares.

Rhea-AI Summary

Haug Kyle reported acquisition or exercise transactions in this Form 4 filing.

Dominari Holdings Inc. director Kyle Haug received a grant of 25,000 shares of common stock as restricted stock pursuant to the company’s 2022 Equity Incentive Plan. The footnote states these granted shares vested on January 9, 2026. Following the award, Haug directly holds 49,409 common shares.

Rhea-AI Summary

Wool Kyle Michael reported acquisition or exercise transactions in this Form 4 filing.

Dominari Holdings Inc. reported that President and director Kyle Michael Wool received a grant of 3,000,000 shares of common stock as a compensation award. The shares were granted at a price of $0.00 per share, so no cash changed hands in this transaction.

The award was made under the company’s 2022 Equity Incentive Plan. It was initially granted on January 7, 2026 and became effective only after stockholders approved an amendment to the plan on March 4, 2026 and the shares were registered on Form S-8 on March 13, 2026. The shares were issued to Wool on March 18, 2026, bringing his direct holdings to 4,211,828 shares of common stock following the transaction.

Rhea-AI Summary

Blattner Gregory James reported acquisition or exercise transactions in this Form 4 filing.

Dominari Holdings Inc. reported that director Gregory James Blattner received a grant of 25,000 shares of common stock as restricted stock on January 9, 2026 under the 2022 Equity Incentive Plan. The award vested in full the same day, bringing his direct holdings to 47,411 shares.

Rhea-AI Summary

Parsley Brian Keith reported acquisition or exercise transactions in this Form 4 filing.

Dominari Holdings Inc. director Brian Keith Parsley received a grant of 25,000 shares of common stock as restricted stock under the company’s 2022 Equity Incentive Plan. The footnote states that all 25,000 granted shares vested on January 9, 2026, and he now directly owns 25,000 shares.

Rhea-AI Summary

Dominari Holdings Inc. reported that its COO, Christopher Franklin Devall, received a grant of 10,000 shares of restricted common stock on December 11, 2025. After this award, he beneficially owns 155,702 shares of the company’s common stock in direct ownership. The grant was made under the company’s 2022 Equity Incentive Plan, and the restricted shares are scheduled to vest on December 11, 2026.

Rhea-AI Summary

Dominari Holdings director Ronald Craig Lieberman received 150,000 restricted shares on February 18, 2025 under an Advisory Board Agreement, bringing his reported direct common stock holdings to 181,613 shares. He also holds outstanding Series A warrants exercisable at $3.72 and Series B warrants exercisable at $4.22, each expiring February 14, 2030, representing 21,613 underlying shares per series (43,226 total).

The restricted shares were issued as compensation and the warrants were purchased in a private placement that closed February 12, 2025 at a combined offering price of $3.47 per warrant package.

Rhea-AI Summary

Ronald Craig Lieberman, a director of Dominari Holdings Inc. (DOMH), reported transactions dated 02/10/2025 involving both common stock and warrants from a private placement and a restricted stock grant. He purchased 21,613 common shares as part of the issuer's private placement that closed 02/12/2025, receiving accompanying Series A and Series B warrants exercisable 02/12/2025 through 02/12/2030. The combined private placement price was $3.47 per unit. Separately, he was granted 10,000 restricted shares at $3.22 per share under the 2022 Equity Incentive Plan, bringing his total reported ownership to 31,613 shares.

Rhea-AI Summary

Insider sale reported by Dominari Holdings Inc. (DOMH) — Director Gregory James Blattner sold 14,409 shares of the company's common stock on 09/23/2025 at an average price of $7.99 per share, according to the Form 4 filing. After the sale, Mr. Blattner beneficially owned 22,411 shares. The transaction reduces his reported direct holdings from 36,820 shares to 22,411 shares, reflecting a significant disposition of common stock while remaining a reporting director. The filing discloses the number of shares sold, the average price, and the post-transaction ownership level.